Index
1 Market Overview of Metastatic Colorectal Cancer Surgery
1.1 Metastatic Colorectal Cancer Surgery Market Overview
1.1.1 Metastatic Colorectal Cancer Surgery Product Scope
1.1.2 Metastatic Colorectal Cancer Surgery Market Status and Outlook
1.2 Global Metastatic Colorectal Cancer Surgery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metastatic Colorectal Cancer Surgery Market Size by Region (2018-2029)
1.4 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Region (2018-2023)
1.5 Global Metastatic Colorectal Cancer Surgery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.2 Europe Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.4 Latin America Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.5 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
2 Metastatic Colorectal Cancer Surgery Market by Type
2.1 Introduction
2.1.1 Tumor Resection
2.1.2 Portal Vein Embolization
2.2 Global Metastatic Colorectal Cancer Surgery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2018-2023)
2.2.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
3 Metastatic Colorectal Cancer Surgery Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Cancer Research Centers
3.2 Global Metastatic Colorectal Cancer Surgery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2018-2023)
3.2.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
4 Metastatic Colorectal Cancer Surgery Competition Analysis by Players
4.1 Global Metastatic Colorectal Cancer Surgery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2022)
4.3 Date of Key Players Enter into Metastatic Colorectal Cancer Surgery Market
4.4 Global Top Players Metastatic Colorectal Cancer Surgery Headquarters and Area Served
4.5 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
4.6 Competitive Status
4.6.1 Metastatic Colorectal Cancer Surgery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.1.4 Sanofi Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.2.4 Roche Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.3.4 Eli Lilly Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.4.4 Pfizer Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.5.4 Novartis Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.6.4 Amgen Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Taiho Oncology
5.7.1 Taiho Oncology Profile
5.7.2 Taiho Oncology Main Business
5.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.7.4 Taiho Oncology Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.7.5 Taiho Oncology Recent Developments
5.8 Genentech
5.8.1 Genentech Profile
5.8.2 Genentech Main Business
5.8.3 Genentech Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.8.4 Genentech Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.8.5 Genentech Recent Developments
5.9 EMD Serono
5.9.1 EMD Serono Profile
5.9.2 EMD Serono Main Business
5.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.9.4 EMD Serono Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.9.5 EMD Serono Recent Developments
5.10 Suzhou Zelgen Biopharmaceuticals
5.10.1 Suzhou Zelgen Biopharmaceuticals Profile
5.10.2 Suzhou Zelgen Biopharmaceuticals Main Business
5.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.10.4 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.10.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metastatic Colorectal Cancer Surgery Market Dynamics
11.1 Metastatic Colorectal Cancer Surgery Industry Trends
11.2 Metastatic Colorectal Cancer Surgery Market Drivers
11.3 Metastatic Colorectal Cancer Surgery Market Challenges
11.4 Metastatic Colorectal Cancer Surgery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List